Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First-in-human data disclosed on NIBR-6465

Oct. 13, 2010

Snapshots: Recent data on the antibacterial activity of CXA-101

Oct. 13, 2010

Pfizer's antibacterial MC-1 shows promising preclinical activity

Oct. 13, 2010

DC-based TaReNef AIDS vaccine is safe and immunogenic in phase I/II trial

Oct. 13, 2010

AGI-101 improves postsurgery survival in high-risk melanoma

Oct. 11, 2010

Tasocitinib meets primary endpoint in phase II psoriasis trial

Oct. 11, 2010

PP-9706642 shows promise as a prophylactic/therapeutic agent for HSV-2 infection

Oct. 11, 2010

Debio-0719 suppresses metastasis in mouse models of breast cancer

Oct. 11, 2010

PTC-299/aromatase inhibitor combinations deemed feasible in breast cancer trial

Oct. 11, 2010

MV-062926 is active in mouse model of COPD

Oct. 8, 2010

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...